Transdermal delivery using a novel electrochemical device, part 2: In Vivo study in humans

Journal of Pharmaceutical Sciences

Volumn 101, Issue 6, 2012, Pages 2262-2268

  Schröder, Britta ^a   Nickel, Ulrich ^b   Meyer, Elisabeth ^a   Lee, Geoffrey ^b  

^a Acino AG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Electrochemical patch; Fentanyl; In vivo; Transdermal

Indexed keywords

FENTANYL; WATER;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG RELEASE; ELECTRIC POTENTIAL; ELECTROCHEMICAL TRANSDERMAL PATCH; ELECTRODE; ELECTROLYSIS; HUMAN; HUMAN TISSUE; HYDROGEL; IN VIVO STUDY; MALE; NORMAL HUMAN; TRANSDERMAL PATCH;

EID: 84859738752     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23108     Document Type: Article

References (23)

1. Schröder B, Nickel U, Meyer E, Lee G. 2012. Transdermal delivery using a novel electrochemical device I: Device design and in vitro release/permeation of fentanyl. J Pharm Sci 101:245-255.
2. Jadoul A, Bouwstra J, Preat VV. 1999. Effects of iontophoresis and electroporation on the stratum corneum. Review of the biophysical studies. Adv Drug Deliv Rev 35:89-105.
3. Grond S, Radbruch L, Lehmann KA. 2000. Clinical pharmacokinetics of transdermal opioids. Focus on transdermal fentanyl. Clin Pharmacokinet 38:59-89.
4. Gupta SK, Bernstein KJ, Noorduin H, Van Peer A, Sathyan G, Haak R. 1998. Fentanyl delivery from an electrotransport system. Delivery is a foundation of total current, not duration of current. J Clin Pharmacol 38:951-958.
5. Sathyan G, Jaskowiak J, Evashenk M, Gupta S. 2005. Characterisation of the pharmacokinetics of the fentanyl HCl patient-controlled transdermal system (PCTS): Effect of current magnitude and multiple-day dosing and comparison with iv fentanyl administration. Clin Pharmacokinet 44:7-15.
6. Bronaugh RL, Steart RF, Congdon ER. 1982. Methods for in vitro percutaneous absorption studies II: Animal models for human skin. Toxicol Appl Pharmacol 62:481-488.
7. Sathayn G, Phipps B, Grupta SK. 2009. Passive absorption of fentanyl from the fentanyl HCl iontophoretic transdermal system. Curr Med Res Opin 25:363-366.
8. Gourlay GK, Kowalski SR, Plummer JL, Cousins MJ, Armstrong PJ. 1988. Fentanyl blood concentration-analgesic response relationship in the treatment of postoperative pain. Anesth Analg 67:329-337.
9. Jeal W, Benfield P. 1997. Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pair control. Drugs 53:109-138.
10. Thysmann S, Tasset C, Preat V. 1994. Transdermal iontophoresis of fentanyl: Delivery and mechanistic analysis. Int J Pharm 101:105-113.
11. Duthie DJ, Rowbotham DJ, Wyld R, Henderson PD, Nimmo WS. 1988. Plasma fentanyl concentrations during transdermal delivery of fentanyl to surgical patients. Br J Anaesth 60:614-618.
12. Holley FO, van Steennis C. 1988. Postoperative analgesia with fentanyl: Pharmacokinetics and pharmacodynamics of constant-rate i.v. and transdermal delivery. Br J Anaesth 60:608-613.
13. Trescot AM, Datta S, Lee M, Hansen H. 2008. Opioid pharmacology. Pain Physician 11:133-153.
14. Chelly JE. 2005. An iontophoretic fentanyl HCl patient-controlled transdermal system for acute postoperative pain management. Expert Opin Pharmacother 6:1205-1214.
15. Han T, Harmatz JS, Greenblatt DJ, Martyn JA. 2007. Fentanyl clearance and volume of distribution are increased in patients with major burns. J Clin Pharmacol 47:674-680.
16. McClain DA, Hug CC Jr. 1980. Intravenous fentanyl kinetics. Clin Pharmacol Ther 28:106-114.
17. Reilly CS, Wood AJ, Wood M. 1985. Variability in fentanyl pharmacokinetics in main. Computer predicted plasma concentrations for three intravenous dosage regimens. Anasthesia 40:837-843.
18. Scott JC, Stanski DR. 1987. Decreased fentanyl and alfentanil requirements with age: A simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther 240:159-166.
19. Roy SD, Flynn GL. 1989. Transdermal delivery of narcotic analgesics: Comparative permeabilities of narcotic analgesics through human cadaver skin. Pharm Res 6:825-832.
20. Woodhouse A, Mather LE. 2000. The minimum effective concentration of opioids: A revisitation with patient controlled analgesia fentanyl. Reg Anesth Pain Med 25(3):259-267.
21. Peng PW, Sandler AN. 1999. A review of the use of fentanyl analgesia in the management of acute pain in adults. Anesthesiology 90(2):576-599.
22. Lehmann KA, Heinrich C, van Heiss R. 1988. Balanced anesthesia and patient controlled postoperative analgesia with fentanyl: Minimum effective concentrations, accumulation and acute tolerance. Acta Anaesthesiol Belg 39(1):11-23.
23. Gourlay GK, Kowalski SR, Plummer JL, Cherry DA, Gaukroger P, Cousins MJ. 1989. The transdermal administration of fentanyl in the treatment of postoperative pain: Pharmacokinetics and pharmakodynamic effects. Pain 37(2):193-202.